Established in 1980, EIPICO sells about 300 million units annually and exports to 60 countries, with exports accounting for 22% of its total business. The company operates three factories, featuring 51 production lines and producing over 400 pharmaceutical products. In January 2026, its joint venture with ACDIMA and the Suez Canal Economic Zone Company, Arab API, began building a $165 million factory in Egypt to localise pharmaceutical ingredient production. The Arab Company for Drug Industries & Medical Appliances owns a 51.3% stake in EIPICO.